Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Caris Life Sciences, Inc. CAI

Set alert

Price alert · CAI

All alert types
33.69 USD +1.59 +4.94%

As of Nov 3, 10:34 AM ET

Bid
33.64 × 1
Ask
33.74 × 1
32.14 Day range 33.88
14.19 52-week range 36.50
YTD
+24.85%
1 year
+12.51%
Open
32.27
Prev close
32.10
Mkt cap
9.54B
Vol
444.66K
Avg vol
4.83M
EPS
1.69
P/E
19.97
Div yield
0.00%
More statistics
Low
32.14
High
33.88
Forward P/E
86.31
Beta
0.00
Short ratio
2.63
Inst. own
57.40%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
29.16
200-d avg
21.58
1y target
32.46

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 12, 2025Earnings: -0.54; estimate -0.21; surprise -157.14%
  • Nov 5, 2025Earnings: 0.08; estimate -0.08; surprise 200%
  • Feb 26, 2026Earnings: 0.28; estimate 0.01; surprise 2700%
  • May 7, 2026Earnings: -0.0018; estimate -0.02; surprise 91%
  • Aug 5, 2026Earnings: -0.0023; estimate 0.00587; surprise -139.18%
  • Aug 6, 2026Rating: Evercore ISI Group · Outperform → Outperform
  • Sep 9, 2026Rating: UBS · — → Neutral
  • Oct 13, 2026Rating: TD Cowen · Buy → Buy
  • Oct 14, 2026Rating: JP Morgan · Overweight → Overweight
  • Oct 19, 2026Rating: Canaccord Genuity · Hold → Hold
  • Oct 27, 2026Rating: BTIG · Buy → Buy
  • Nov 4, 2026Earnings: —; estimate 0.02814; surprise —%
Signals (124)
NameDateAgo
SMA: BullishNov 3, 20261 hour ago
SMA: BearishNov 2, 20261 day ago
RSI: OverboughtOct 28, 20266 days ago
MACD: Buy SignalOct 21, 20261 week ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BearishOct 6, 20264 weeks ago
MACD: Sell SignalOct 1, 20261 month ago
SMA: BearishSep 30, 20261 month ago
RSI: OverboughtSep 17, 20261 month ago
MACD: Buy SignalSep 16, 20261 month ago
RSI: OverboughtSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 1, 20262 months ago
MACD: Sell SignalSep 1, 20262 months ago
RSI: OverboughtAug 20, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BearishAug 18, 20262 months ago
SMA: BullishAug 6, 20262 months ago
RSI: OverboughtAug 6, 20262 months ago

Newest 20 of 124.

Financial health

Altman Z-Score

7.69 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -14.1×
FY 2015: 21.7×FY 2016: 90.3×FY 2017: 7.5×FY 2018: 7.1×FY 2019: 16.3×FY 2020: 18.1×FY 2022: -17.8×FY 2023: -15.4×FY 2024: -10.4×FY 2025: -14.1×
FY 2015 5y median -14.1× FY 2025
P/S 9.4×
FY 2015: 2.3×FY 2016: 1.8×FY 2017: 1.5×FY 2018: 1.3×FY 2019: 1.2×FY 2020: 1.7×FY 2022: 27.6×FY 2023: 23.3×FY 2024: 17.3×FY 2025: 9.4×
FY 2015 5y median 17.3× FY 2025
P/B 13.2×
FY 2015: 1.3×FY 2016: 1.2×FY 2017: 1.0×FY 2018: 0.8×FY 2019: 0.7×FY 2020: 0.7×FY 2022: -4.2×FY 2023: -3.3×FY 2024: -2.9×FY 2025: 13.2×
FY 2015 5y median -2.9× FY 2025
P/FCF 114×
FY 2015: -2.4×FY 2016: -4.4×FY 2017: -1.6×FY 2018: -0.9×FY 2019: -7.7×FY 2020: 8.7×FY 2022: -21.8×FY 2023: -23.9×FY 2024: -28.1×FY 2025: 114×
FY 2015 5y median -21.8× FY 2025
EV/EBITDA 633×
FY 2015: 10.8×FY 2016: 12.4×FY 2017: 9.9×FY 2018: 9.4×FY 2019: 10.3×FY 2020: 8.6×FY 2022: -29.7×FY 2023: -28.0×FY 2024: -40.9×FY 2025: 633×
FY 2015 5y median -28.0× FY 2025
EV/Sales 8.9×
FY 2015: 7.9×FY 2016: 6.7×FY 2017: 6.3×FY 2018: 6.2×FY 2019: 6.1×FY 2020: 7.5×FY 2022: 28.2×FY 2023: 23.8×FY 2024: 18.2×FY 2025: 8.9×
FY 2015 5y median 18.2× FY 2025
FCF Yield 0.9%
FY 2015: -41.6%FY 2016: -22.6%FY 2017: -64.4%FY 2018: -114.1%FY 2019: -12.9%FY 2020: 11.5%FY 2022: -4.6%FY 2023: -4.2%FY 2024: -3.6%FY 2025: 0.9%
FY 2015 5y median -3.6% FY 2025

Profitability

Gross Margin 66.4%
FY 2015: 50.4%FY 2016: 46.7%FY 2017: 48.6%FY 2018: 49.4%FY 2019: 48.1%FY 2020: 62.6%FY 2022: 31.0%FY 2023: 29.2%FY 2024: 43.4%FY 2025: 66.4%
FY 2015 5y median 43.4% FY 2025
Operating Margin 5.6%
FY 2015: 27.3%FY 2016: 22.4%FY 2017: 30.3%FY 2018: 34.4%FY 2019: 31.3%FY 2020: 47.3%FY 2022: -122.2%FY 2023: -104.4%FY 2024: -62.4%FY 2025: 5.6%
FY 2015 5y median -62.4% FY 2025
Net Margin -66.2%
FY 2015: 10.7%FY 2016: 2.0%FY 2017: 20.7%FY 2018: 18.2%FY 2019: 7.4%FY 2020: 9.4%FY 2022: -124.1%FY 2023: -111.5%FY 2024: -68.4%FY 2025: -66.2%
FY 2015 5y median -68.4% FY 2025
ROE -93.2%
FY 2015: 5.8%FY 2016: 1.3%FY 2017: 12.8%FY 2018: 11.2%FY 2019: 4.5%FY 2020: 3.9%FY 2022: 18.8%FY 2023: 15.9%FY 2024: 11.3%FY 2025: -93.2%
FY 2015 5y median 11.3% FY 2025
ROIC 4.5%
FY 2015: 3.0%FY 2016: 2.0%FY 2017: 4.6%FY 2018: 5.0%FY 2019: 4.3%FY 2020: 5.3%FY 2022: -49.5%FY 2023: -98.5%FY 2024: -105.2%FY 2025: 4.5%
FY 2015 5y median -49.5% FY 2025
ROA -47.8%
FY 2015: 1.4%FY 2016: 0.3%FY 2017: 3.0%FY 2018: 2.6%FY 2019: 1.1%FY 2020: 1.1%FY 2022: -44.7%FY 2023: -82.7%FY 2024: -82.0%FY 2025: -47.8%
FY 2015 5y median -47.8% FY 2025

Growth (YoY)

Revenue 97.0%
FY 2015: 9.7%FY 2016: 17.9%FY 2017: 18.4%FY 2018: 24.0%FY 2019: -3.6%FY 2020: -29.4%FY 2022: 0.0%FY 2023: 18.4%FY 2024: 34.7%FY 2025: 97.0%
FY 2015 FY 2025
Operating Income 117.5%
FY 2015: -29.8%FY 2016: -3.1%FY 2017: 60.2%FY 2018: 40.8%FY 2019: -12.4%FY 2020: 6.8%FY 2022: 0.0%FY 2023: -1.2%FY 2024: 19.5%FY 2025: 117.5%
FY 2015 FY 2025
EPS (diluted) 31.1%
FY 2015: -55.1%FY 2016: -75.8%FY 2017: 1087.1%FY 2018: 7.9%FY 2019: -56.7%FY 2020: -9.9%FY 2022: 0.0%FY 2023: -15.9%FY 2024: -48.4%FY 2025: 31.1%
FY 2015 FY 2025
Free Cash Flow 126.4%
FY 2015: -44.4%FY 2016: 49.6%FY 2017: -184.4%FY 2018: -82.5%FY 2019: 89.7%FY 2020: 188.4%FY 2022: 0.0%FY 2023: 9.0%FY 2024: 15.0%FY 2025: 126.4%
FY 2015 FY 2025

Financial Health

Current Ratio 7.8×
FY 2015: 0.7×FY 2016: 0.8×FY 2017: 0.5×FY 2018: 0.5×FY 2019: 1.7×FY 2020: 0.7×FY 2022: 3.8×FY 2023: 2.6×FY 2024: 1.3×FY 2025: 7.8×
FY 2015 5y median 2.6× FY 2025
Quick Ratio 7.8×
FY 2015: 0.7×FY 2016: 0.8×FY 2017: 0.5×FY 2018: 0.5×FY 2019: 1.7×FY 2020: 0.7×FY 2022: 3.4×FY 2023: 2.0×FY 2024: 1.1×FY 2025: 7.8×
FY 2015 5y median 2.0× FY 2025
Debt / Equity 0.7×
FY 2015: 3.1×FY 2016: 3.2×FY 2017: 3.0×FY 2018: 3.1×FY 2019: 3.0×FY 2020: 2.5×FY 2022: -0.2×FY 2023: -0.1×FY 2024: -0.2×FY 2025: 0.7×
FY 2015 5y median -0.1× FY 2025
Net Debt / EBITDA -36.8×
FY 2015: 7.6×FY 2016: 9.0×FY 2017: 7.5×FY 2018: 7.5×FY 2019: 8.3×FY 2020: 6.7×FY 2022: -0.7×FY 2023: -0.6×FY 2024: -2.0×FY 2025: -36.8×
FY 2015 5y median -0.7× FY 2025
Interest Coverage 0.8×
FY 2015: 1.9×FY 2016: 1.5×FY 2017: 2.0×FY 2018: 1.9×FY 2019: 1.6×FY 2020: 2.3×FY 2022: -11.8×FY 2023: -10.1×FY 2024: -5.1×FY 2025: 0.8×
FY 2015 5y median -5.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.6%FY 2019: 1.8%FY 2020: 3.5%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 4.1%FY 2019: 28.5%FY 2020: 63.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31